Cargando…
Use of sulforaphane in COVID-19: Clinical trials are needed
We read with interest the narrative review authored by Kiser et al. (2021), which discussed extensively the antioxidant effect and anti-inflammatory effect of sulforaphane, a dietary supplement found in high amounts in cruciferous vegetables that ais orally accessible and well-tolerated. Notably, in...
Autores principales: | Kow, Chia Siang, Ramachandram, Dinesh Sangarran, Hasan, Syed Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898664/ https://www.ncbi.nlm.nih.gov/pubmed/35303531 http://dx.doi.org/10.1016/j.molimm.2022.03.001 |
Ejemplares similares
-
Metformin in COVID-19: clinical trials are needed to prove its benefits
por: Kow, Chia Siang, et al.
Publicado: (2022) -
The use of dornase alfa in patients with COVID-19
por: Ramachandram, Dinesh Sangarran, et al.
Publicado: (2023) -
Statin use in patients with diabetes amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022) -
Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021) -
Colchicine for COVID-19: Hype or hope?
por: Kow, Chia Siang, et al.
Publicado: (2022)